
    
      The study is to be conducted as an open-label, randomized, single-dose, 2-way crossover,
      relative bio availability study performed on 200 healthy adult volunteers. A total 200
      subjects will be assessed for AUC for 72 hours after administration of flucanazole suspension
    
  